Classic Country Theatre

Business and Change – The influence of Eric Lefkofsky September 10, 2017

Eric Lefkofsky is described by most as an entrepreneur and philanthropist and has a fascinating life story that has led him to where he is today. Born in 1969 he was one of three children in the household. After he finished high school he pursued law at the University of Michigan and eventually completed his program, receiving a Juris Doctor in 1993 and learn  more about Eric.

After completing school Lefkofsky began his journey through into the entrepreneurial world along side a friend from college who together purchased an apparel company. Over the next several years Lefkofsky would be a part of several other businesses and eventually would come to co-found his current focus, Tempus. Lefkofsky currently serves as the CEO for Tempus.

Tempus broadly speaking is a technology company, and specifically, focuses on aiding doctors in combating cancer. They do this by supplying physicians with a transcription of genomes and in combination with their research data can produce personalized results for patients on an individual basis that could potentially help with their treatment.

Beyond his entrepreneurial endeavors, Lefkofsky has also made his mark in the world of philanthropy. In 2006 along side his wife, Lefkofsky created the Lefkofsky Family Foundation. The foundation is a private foundation with the purpose of providing quality education to youth, protecting basic human rights and helping to pilot new medical research. In addition to creating the foundation, Lefkofsky is a current member of The Giving Pledge, a charitable organization which focuses on promoting the wealthiest members of the planet to give away a large portion of their wealth to aid in charity work.

Today Lefkofsky spends most of his time in Chicago where he is very involved in the community. He is on the board of directors for The Art Institute of Chicago, The Museum of Science and Industry and the Children’s Memorial Hospital. He also lectures at career business schools in the area about entrepreneurship and technology-based business and more information click here.

More Visit:

No Comments on Business and Change – The influence of Eric Lefkofsky

Mikhail Blagosklonny Wanted a Way to Help Cancer Patients September 1, 2017

Even after Mikhail Blagosklonny had treated many different cancer patients and after he had dedicated his life to their treatment, he knew that he would have to do something that would make an even bigger difference in the cancer treatment world if he wanted to actually help more people out with the issues that they had. He was well aware of all of the issues of communication between different people and between the others who were in the same situations as him and that is what has allowed Mikhail Blagosklonny the chance to experience more out of the practice that he has.He wanted other oncologists to be able to do this, too. Not only did he want them to actually be successful on their own but he also wanted them to be successful so that they could treat more patients and make their lives better. This is what made sense to Mikhail Blagosklonny and what allowed him the chance to continue working hard so that he could help other people out and allow them to actually treat their own patients with the things that they had learned about from the publication that he was going to set up.

Oncotarget was the perfect answer to everything that Mikhail Blagosklonny wanted to do. It was a great way for him to try and do things and it was something that made it easy for him to make the right choices in his business. Even when Mikhail Blagosklonny was doing what he could to show people what they needed, Oncotarget was still something that was going to make a difference and was something that was going to change the way that things were done for different people who tried their best to experience more out of the situations that they were in.For Mikhail Blagosklonny to do all of this, he had to work hard at Oncotarget. He also had to work to ensure that he was doing things the right way and that he was allowing people the chance to experience more in their own situations.

For Oncotarget to be as successful as what he wanted, he chose to include other specialists. The most important thing that these people did was provide valuable insight into what was going on and what they would be able to do to get more from the best cancer treatment that they were dealing with so that they would be as successful as possible.When Mikhail Blagosklonny first created Oncotarget, he knew what he could do and how he would be able to experience more for his practice. He liked all of his patients and he also liked the fact that his patients knew a lot of the things that he was doing. He tried his best to always keep them informed so that they would be able to know what he was doing with cancer treatment and the other things that he did to make the patients more comfortable while fighting a horrific type of disease.

No Comments on Mikhail Blagosklonny Wanted a Way to Help Cancer Patients

Oncotarget is changing the Globe August 12, 2017

Oncotarget is one of the most respected scientific journals in the world. The journal is known to be multidisciplinary, meaning that it publishes different academic subjects. The chief editors of the famous journal are Mikhail Blagosklonny and the famous Andrei V. Gudkov. These two individuals are known because of their skills in scientific research, and they have changed the lives of many students through their journal.

Since it was established, the scientific journal has covered some of the complex subjects in the industry. Some of these subjects include cancer, ageing, atherosclerosis, neurodegeneration, microbes, cancer cells and neurons. Thanks to Oncotarget, individuals in the international platform can access some of the latest advancements in the world.

The mission of the successful scientific journal is making some of the complex results available to the general republic in a fast and reliable way. The journal achieves its mission by making sure that the results and surveys are authentic before they have been published. When research is completed, several professors read it and makes sure that the content is not fake. This has earned the trust of many people around the world because everything posted is factual.

The professors associated with the Oncotarget journal are well experienced and qualified. These individuals have specialized in different subjects, and they have the knowledge to know the facts and lies. These specialists have played a fundamental role in the success of the scientific journal. Mikhail, one of the chief editors of the journal has been in the research industry for a long time, and he has contributed a lot, especially in the matters concerning cancer and ageing.

Just recently Mikhail and his team published some information regarding the use of the e-cigar. According to the journal, specialists at one of the prestigious universities had carried out a study, and the results proved that the use of the electronic cigars is not safe for the teeth and gums. Most of the individuals who smoke these modern cigars are prone to hazardous and fatal diseases. The journal states that the electronic cigars are harmful and should not be used by young people who consider them to be fashionable.

To know more click here

No Comments on Oncotarget is changing the Globe

The A – Z Guide of Eric Lefkofsky and Tempus March 26, 2017

Eric is the CEO and co-founder of Tempus, a technology company that built a system to help fight cancer. Apart from Tempus, he is the founding partner of Lightbank – a venture fund that invests in disruptive tech, Groupon – global e-commerce market and uptake technologies, which is the number one predictive analytics platform for the world’s largest companies. Others are MediaOcean, Echo Global Logistics, and InnerWorkings.Ten years ago – 2006, together with his wife Liz, Eric started the Lefkofsky Family Foundation. This charitable foundation helps advance high impact initiatives in the community. Eric also serves as a trustee of other institutions such as The Art Institute of Chicago. He is also a board member at Steppenwolf Theatre Company and an adjunct professor at the University of Chicago. Follow Eric on Twitter (@lefkofsky) and Facebook (@eplefkofsky) to know more about him.

ChicagoInno article recap

The article was about how Eric Lefkofsky’s Tempus used data to help fight breast cancer by giving University of Chicago doctor’s data. The startup announced the partnership on Thursday. It will provide analysis and molecular sequencing to UChicago’s breast cancer specialists to come up with effective treatment plans for cancer patients. Tempus will sample data from more than one thousand patients to help cancer specialists know patterns that can predict how patients react to treatment. This data will lead to better treatment over time, which is the primary goal of the deal.

According to Dr. Olufunmilayo Olopade, a professor, and dean at the University of Chicago, there is less accessible data on former breast cancer patients. This is despite it being a common type of cancer. He added that they were excited to collaborate with Tempus on the initiative.Tempus was founded in 2015, and it uses genomic sequencing and machine learning to help cancer specialists make effective treatment decisions. Its headquarters is 600 W. Chicago. UChicago is one of the latest strings of partners. They are working with Mayo Clinic, University of Michigan, Penn Medicine, Robert H. Lurie Cancer Center of Northwestern University, and Rush University Medical Center to use data to fight breast cancer.

No Comments on The A – Z Guide of Eric Lefkofsky and Tempus